GL1X · GenesisL1 explorer

MolNFT v2 · #209772 · protein

Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor

8FJX: “Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor”. X-ray diffraction at 2.17, 2 ligands (Y7L, GAR). MolNFT v2 #209772 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
8FJX
Type
protein
Length
200 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.17
Source
Homo sapiens
UniProt
P22102
Ligands
Y7L, GAR

Structure

x-ray diffraction · resolution 2.17 · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein200—P22102

Ligands and binding sites

  • Y7L · N-{5-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]thiophene-2-carbonyl}-L-glutamic acid · ligand · chains A
  • GAR · Glycinamide ribonucleotide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.